CBio
CBio A/S is a company dedicated to making cancer a curable disease by enabling its partners to develop and bring T-cell based therapies faster to cancer patients worldwide.
CBio has raised €1.3M across 1 funding round from 3 investors, most recently a round in Oct 2021. Based in Copenhagen, Denmark; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€1.3M
€1,344,556
Funding rounds
1
Investors
3
distinct backers
Active since
2021-10
latest 2021-10
Funding by year
EUR raised per yearCBio — funding by year — interactive chart.
Data table
| CBio — funding by year | |
|---|---|
| 2021 | €1.3M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-10-04 | Other | €1.3M | Christian Leroy,Klaus Edvardsen,Ludvig Find | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData